Current studies have shown that PHD2 expression was reduced in endothelial cells at the lesion sites of the pulmonary arteries in idiopathic PAH patients, and the loss of PHD2 in endothelial cells activates HIF2α rather than HIF1α (Dai et al., 2016). This evidence concerns the gene HIF1A and pulmonary arterial hypertension.